Navigation Links
Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results
Date:8/13/2009

2 million, or $1.09 per share, compared to a net loss of $18.2 million, or $1.23 per share, for fiscal 2008.

Cash, cash equivalents and investments at June 30, 2009 were $5.3 million, compared to $8.4 million at March 31, 2009 and $23.3 million at June 30, 2008. As of June 30, 2009, Cardica had approximately 15.8 million common shares outstanding.

Milestones for Fiscal 2010

Cardica expects to achieve the following milestones over the course of fiscal 2010:

  • Begin selling C-Port(R) X-CHANGEII(TM);
  • Build a sales organization of 25 to 30 total sales representatives, including a direct salesforce, independent distributors and manufacturer's representatives, to support the sales effort for the C-Port and PAS-Port systems;
  • Complete animal testing of the Cardica Microcutter for general and thoracic surgery;
  • Complete tooling of Cardica Microcutter; and
  • Achieve additional milestones under Cardica's agreement with Cook for the development of a closure device for patent foramen ovale.

Financial Guidance for 2010

As Cardica transitions its cardiac surgery business to a small core direct sales force supported by independent distributors and manufacturer's representatives, Cardica is not able to provide product revenue guidance for fiscal 2010. For fiscal 2010, Cardica expects that research and development and sales, general and administrative expenses will total between $11 and $13 million, including non-cash stock-based compensation expense of approximately $1 million. Cardica expects its cash and cash equivalents to decline by approximately $2.5 million per quarter in fiscal 2010, without giving effect to any financing transactions.

Conference Call Details

Cardica's management will host a conference call today, August 13, 2009, at 4:30
'/>"/>

SOURCE Cardica, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Cardica Announces Proposed Public Offering of Common Stock
2. Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock
3. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
4. Cardica Announces Exercise of Over-Allotment Option
5. Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday, January 24, 2008
6. Cardicas C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University
7. Cardicas C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study
8. Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, April 29, 2008
9. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
10. Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons
11. Cardica Names Frederick Bauer Vice President of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 23, 2014 Cancer researchers in New ... between intercellular communication tunnels and the growth and spread ... story on the Surviving Mesothelioma website. , ... University of Minnesota have just released their study on ... materials between cells. They found that mesothelioma cells ...
(Date:11/22/2014)... A classic black prom dress will never go ... suppliers, has unveiled its new items of black prom ... at a big discount, up to 70% off. People throughout ... new black prom dresses, made with the best materials, can ... of all customers, the company provides these beautiful outfits in ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding dresses, ... business offers a wide range of special occasion dresses, ... them to create multiple looks easily. , According to ... of chic wedding dresses has been prepared for many ... rates now. Dylan Queen can always create what ladies ...
(Date:11/22/2014)... November 22, 2014 Discount-Dress.com is ... of the firm is to increase the company’s online market ... a new selection of bridesmaid dresses and announced a bridesmaid ... is valid until Dec. 30, 2014. All the dresses from ... inexpensive. , In fact, Discount-Dress.com is very good at ...
(Date:11/22/2014)... "My friend went in for a mammogram ... said an inventor from Cambria Heights, N.Y. "To add ... second time because the first results were inaccurate. Her ... patent-pending MAMO EASY to offer a more comfortable way ... patient from the pain normally involved with this procedure. ...
Breaking Medicine News(10 mins):Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:New Black Prom Dresses from BellasDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2
... ST. LOUIS, May 12 Allied Healthcare Products, Inc. (Nasdaq: ... the third quarter ending March 31, 2009, declined from about ... period, to a loss of about $450,000, or a negative ... the third quarter declined about 11 percent, or $1.5 million, ...
... May 12 With today,s release of the ... showing that the nation,s two largest programs are ... urged politicians to work together on reforms of ... Reform efforts will need to recognize the underlying ...
... to Depletion According to Latest Projections WASHINGTON , ... trustees, reports issued earlier today highlight the imperative to ... and Medicare, according to the American Academy of ... programs has deteriorated further during the past year and ...
... (NYSE: BMR ) today announced it has commenced ... pursuant to an effective shelf registration statement filed with the ... net proceeds of the offering to repay a portion of ... credit and for other general corporate and working capital purposes. ...
... people have the same genetic disease, why would one person ... or not at all? For a group of genetic diseases ... and Joubert syndrome the answer lies in one gene ... also seems to increase the risk of progressive blindness in ...
... suggests , , TUESDAY, May 12 (HealthDay News) -- Children,s ... cardiac death (DCD), according to researchers, who asked 124 ... about their policies in 2007 and 2008. , The ... that 72 percent of them had DCD policies, while ...
Cached Medicine News:Health News:Allied Healthcare Posts Third Quarter Loss 2Health News:Allied Healthcare Posts Third Quarter Loss 3Health News:Allied Healthcare Posts Third Quarter Loss 4Health News:Allied Healthcare Posts Third Quarter Loss 5Health News:Concord Coalition Says New Trustees' Report Demonstrates the Importance of Health Care Cost Control 2Health News:Actuaries: Trustees' Reports Warn of Looming Financial Challenges Facing Retirement Programs 2Health News:Actuaries: Trustees' Reports Warn of Looming Financial Challenges Facing Retirement Programs 3Health News:BioMed Realty Trust Announces Public Offering of 14,000,000 Shares of Common Stock 2Health News:BioMed Realty Trust Announces Public Offering of 14,000,000 Shares of Common Stock 3Health News:In retinal disease, sight may depend on second sites 2Health News:In retinal disease, sight may depend on second sites 3Health News:Organ Donation Policies Vary Among Children's Hospitals 2
(Date:11/22/2014)... , Nov. 21, 2014  Particle Sciences, ... devices, has developed and manufactured a new innovative ... the Research and Development arm of Exeltis Pharmaceuticals.  ... of Project Management at Particle Sciences, "This vaginal ... utilizing our material sciences and modeling expertise.  We ...
(Date:11/22/2014)... Nov. 21, 2014 Many power shifts ... growing influence of patients in the biopharmaceutical market ... Now, more than ever, understanding how to effectively ... products is essential. According to ... benchmarked companies spent about two-thirds of their patient-focused ...
(Date:11/21/2014)... Nov. 21, 2014  The University of Maryland,s A. ... ceremonial groundbreaking of the new A. James Clark Hall ... building will cultivate transformative new engineering and biomedical technologies ... place at 10:00 a.m. on November 21 at the ... Parking Lot, adjacent to the Jeong H. Kim Engineering ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4
... Study evaluates the efficacy of new device for detecting polyps ... ... Fla., Oct. 7 At the American College of,Gastroenterology Annual ... MD presented results from a,multi-institutional clinical study that evaluated the ...
... by ... with Celiac Disease, Additional Data Indicates Potential in Treating Inflammatory ... Corporation,presented results from two clinical studies this week at the ... CLIN 1001-004, the first Phase IIa trial conducted in celiac ...
Cached Medicine Technology:National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6
Stainless steel construction to withstand sterilization modalities (EtO, Steris®, and Sterrad®) Wide angle of view...
Stainless steel construction to withstand sterilization modalities (autoclave, EtO, Steris®, and Sterrad®) Fully autoclavable, with both distal and proximal ends uniquely soldered for longe...
ENDOlap™ laparoscopes provide excellent image linearity and flatness of field....
Inquire...
Medicine Products: